The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophiliaHCC after HCV eradication in hemophilia Yosuke Inukai; Norihiro Imai; Kenta Yamamoto; Takanori Ito; Yoji Ishizu; Takashi Honda; Shuichi Okamoto; Takeshi Kanematsu; Nobuaki Suzuki; Tadashi Matsushita; Masatoshi Ishigami; Mitsuhiro Fujishiro;

Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations Carolina Delgado Martínez; Mariano Gómez-Rubio; Cecilia Gómez-Domínguez;

Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases Patrizia Burra; Calogero Cammà; Pietro Invernizzi; Fabio Marra; Maurizio Pompili;